Global Biologics and Biosimilars Sales Market Report Forecast 2017-2021

March 2017 | 109 pages | ID: G14A6F1D2A0EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

• United States
• China
• Europe
• Japan

The Major players reported in the market include:
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
Product Segment Analysis:
Biologics
Biosimilars

• Type III

Application Segment Analysis:
Tumor
Diabetes
Cardiovascular

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Application of Biologics and Biosimilars
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
1.4 Biologics and Biosimilars Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Biologics and Biosimilars (2012-2021)
  1.5.1 Global Biologics and Biosimilars Sales and Growth Rate (2012-2021)
  1.5.2 Global Biologics and Biosimilars Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON BIOLOGICS AND BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

3.1 Biologics and Biosimilars Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Biologics and Biosimilars

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Biologics and Biosimilars Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL BIOLOGICS AND BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Biologics and Biosimilars Market Competition by Manufacturers
  5.1.1 Global Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2012-2017)
5.2 Global Biologics and Biosimilars (Volume and Value) by Type
  5.5.1 Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
  5.5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 Global Biologics and Biosimilars (Volume and Value) by Regions
  5.3.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2012-2017)
5.4 Global Biologics and Biosimilars (Volume) by Application

6 UNITED STATES BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Biologics and Biosimilars Sales and Value (2012-2017)
  6.1.1 United States Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 United States Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 United States Biologics and Biosimilars Sales Price Trend (2012-2017)
6.2 United States Biologics and Biosimilars Sales and Market Share by Manufacturers
6.3 United States Biologics and Biosimilars Sales and Market Share by Type
6.4 United States Biologics and Biosimilars Sales and Market Share by Application

7 CHINA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 China Biologics and Biosimilars Sales and Value (2012-2017)
  7.1.1 China Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 China Biologics and Biosimilars Sales Price Trend (2012-2017)
7.2 China Biologics and Biosimilars Sales and Market Share by Manufacturers
7.3 China Biologics and Biosimilars Sales and Market Share by Type
7.4 China Biologics and Biosimilars Sales and Market Share by Application

8 EUROPE BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Biologics and Biosimilars Sales and Value (2012-2017)
  8.1.1 Europe Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Biologics and Biosimilars Sales Price Trend (2012-2017)
8.2 Europe Biologics and Biosimilars Sales and Market Share by Manufacturers
8.3 Europe Biologics and Biosimilars Sales and Market Share by Type
8.4 Europe Biologics and Biosimilars Sales and Market Share by Application

9 JAPAN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Biologics and Biosimilars Sales and Value (2012-2017)
  9.1.1 Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  9.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Biologics and Biosimilars Sales Price Trend (2012-2017)
9.2 Japan Biologics and Biosimilars Sales and Market Share by Manufacturers
9.3 Japan Biologics and Biosimilars Sales and Market Share by Type
9.4 Japan Biologics and Biosimilars Sales and Market Share by Application

10 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Amgen
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 AbbVie
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Johnson & Johnson
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Novo Nordisk
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Novartis
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2021)

13.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2017-2021)
13.2 Global Biologics and Biosimilars Sales Forecast by Regions (2017-2021)
13.3 Global Biologics and Biosimilars Sales Forecast by Type (2017-2021)
13.4 Global Biologics and Biosimilars Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Type in 2015
Table Applications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Global Biologics and Biosimilars Sales and Growth Rate (2012-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Table Global Biologics and Biosimilars Sales of Key Manufacturers (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Manufacturers (2012-2017)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table Global Biologics and Biosimilars Revenue by Manufacturers (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Global Biologics and Biosimilars Sales Growth Rate by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Regions (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Regions (2012-2017)
Figure Global Biologics and Biosimilars Sales Growth Rate by Regions (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Regions (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Regions (2012-2017)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Regions (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Application (2012-2017)
Figure Global Biologics and Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Sales Price Trend (2012-2017)
Table United States Biologics and Biosimilars Sales by Manufacturers (2012-2017)
Table United States Biologics and Biosimilars Market Share by Manufacturers (2012-2017)
Table United States Biologics and Biosimilars Sales by Type (2012-2017)
Table United States Biologics and Biosimilars Market Share by Type (2012-2017)
Table United States Biologics and Biosimilars Sales by Application (2012-2017)
Table United States Biologics and Biosimilars Market Share by Application (2012-2017)
Figure China Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Sales Price Trend (2012-2017)
Table China Biologics and Biosimilars Sales by Manufacturers (2012-2017)
Table China Biologics and Biosimilars Market Share by Manufacturers (2012-2017)
Table China Biologics and Biosimilars Sales by Type (2012-2017)
Table China Biologics and Biosimilars Market Share by Type (2012-2017)
Table China Biologics and Biosimilars Sales by Application (2012-2017)
Table China Biologics and Biosimilars Market Share by Application (2012-2017)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Europe Biologics and Biosimilars Sales by Manufacturers (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Manufacturers (2012-2017)
Table Europe Biologics and Biosimilars Sales by Type (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales by Application (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Application (2012-2017)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Japan Biologics and Biosimilars Sales by Manufacturers (2012-2017)
Table Japan Biologics and Biosimilars Market Share by Manufacturers (2012-2017)
Table Japan Biologics and Biosimilars Sales by Type (2012-2017)
Table Japan Biologics and Biosimilars Market Share by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales by Application (2012-2017)
Table Japan Biologics and Biosimilars Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Biologics and Biosimilars Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2017-2021)
Table Global Biologics and Biosimilars Sales Forecast by Type (2017-2021)
Table Global Biologics and Biosimilars Sales Forecast by Application (2017-2021)